Announced
Harbin Pharmaceutical Group to acquire GNC Holdings for $760m.
Synopsis
Harbin Pharmaceutical Group, a Chinese partially state-owned pharmaceutical manufacturer, agreed to acquire GNC Holdings, a provider of health and nutrition-related products, including vitamins, supplements, minerals, herbs, sports nutrition, diet, and energy products, for $760m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite